HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A further case of confined placental mosaicism for trisomy 2 associated with adverse pregnancy outcome.

AbstractOBJECTIVES:
To add to the knowledge base concerning confined placental mosaicism for trisomy 2.
METHODS:
Cytogenetic study of a late CVS referred for hyperechogenic bowel and raised AFP, and cytogenetic and molecular genetic study of a follow-up amniocentesis. Ultrasound monitoring at regular intervals following the CVS result.
RESULTS:
All cells examined from direct and cultured CVS showed a 47,XY,+2 karyotype. Amniocentesis showed a mosaic 47,XY,+2[8]/46,XY[81] karyotype. Uniparental disomy (UPD) studies on the amniotic fluid showed normal biparental inheritance. The pregnancy developed oligohydramnios and IUGR and resulted in a 26-week liveborn male infant with a 46,XY karyotype, which died after 3 days because of complications of severe prematurity. Placental villi post delivery showed only the 47,XY,+2 cell line.
CONCLUSIONS:
This case represents a further example of confined placental mosaicism (CPM) for trisomy 2 associated with oligohydramnios, IUGR and poor pregnancy outcome.
AuthorsEileen Roberts, J Dunlop, G S Davis, D Churchill, E V Davison
JournalPrenatal diagnosis (Prenat Diagn) Vol. 23 Issue 7 Pg. 564-5 (Jul 2003) ISSN: 0197-3851 [Print] England
PMID12868084 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2003 John Wiley & Sons, Ltd.
Topics
  • Adult
  • Amniocentesis
  • Chorionic Villi Sampling
  • Chromosomes, Human, Pair 2
  • Female
  • Humans
  • Infant, Newborn
  • Karyotyping
  • Male
  • Mosaicism (diagnosis, genetics)
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Diagnosis
  • Trisomy (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: